Skip to content

Effect of bupivacaine liposome on stress response and analgesia during central thoracotomy by intercostal muscle plane block of pectoralis major muscle

Effect of bupivacaine liposome on stress response and analgesia during central thoracotomy by intercostal muscle plane block of pectoralis major muscle

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400091199
Enrollment
Unknown
Registered
2024-10-23
Start date
2024-11-01
Completion date
Unknown
Last updated
2024-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative acute pain

Interventions

Experimental group:The pectoralis major intercostal muscle block was performed with Exparel
Intervention group:The pectoralis major intercostal muscle block was performed with ropivacaine

Sponsors

The First Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) Before the test, understand the nature, significance, possible benefits, possible inconveniences and potential dangers of the test in detail, understand the research procedure and sign the informed consent in person. 2) Patients who plan to undergo elective valve replacement (mitral valve replacement or aortic valve replacement) are operated by the same group of physicians 3) Male and female, age 20-70 years old 4) Male weight =50?, female weight =45?, BMI19.0 ~ 26.0kg/m^2 5) ASA grade ?-? 6) Grade II or III cardiac function, preoperative left ventricular ejection fraction (LVEF) > 40%

Exclusion criteria

Exclusion criteria: 1) The patient refused to participate in the study 2) Previous history of specific allergic diseases (asthma, urticaria, eczema, etc.) or local anesthetics 3) Damage or infection in the chest wall area 4) Abnormal coagulation function, patients with APTT > 33.8s or PT > 12.1s before surgery (33.8 and 12.1 are the reference intervals set by the clinical laboratory of our hospital according to the current normal control value 25.2 and 10.9, respectively, if the normal control value changes, the reference interval will also change accordingly) 5) Complicated coronary heart disease, need intra-aortic balloon counterpulsation support or congestive heart failure 6) Liver and kidney failure 7) History of drug abuse, history of chronic pain, history of mental illness 8) Emergency surgery or secondary surgery

Design outcomes

Primary

MeasureTime frame
Changes of pain score within 24h after surgery;

Secondary

MeasureTime frame
3ml of venous blood was collected before surgery and 1, 2 and 3 days after surgery to detect plasma angiotensin and interleukin6.;The intraoperative dosage of sufentanil, remifentanil and propofol were recorded.;MAP and HR before anesthesia induction, when skin was cut, when sternum was performed, at the beginning of the transfer, at the end of the transfer, 24h and 72h after surgery.;The number of effective analgesic pump compressions was recorded from 12 h, 12 ~ 24h and 24 ~ 48h after surgery.;Extubation time of the patient;Length of stay in ICU;Postoperative exhaust defecation time;Incidence of postoperative pruritus;Time when patients first get out of bed;The incidence of postoperative nausea and vomiting and the use of antiemetic drugs;Length of postoperative hospital stay;Postoperative sleep quality of patients;Popc postoperative pulmonary complications;Patients recovered quality at days 1, 2, 3, and 7;

Countries

China

Contacts

Public ContactShibiao Chen

The First Affiliated H{ospital of Nanchang University

chenlaoshi1111@163.com+86 138 7098 2918

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026